Enwave Corporation Stock
€0.19
Your prediction
Enwave Corporation Stock
Pros and Cons of Enwave Corporation in the next few years
Pros
Cons
Performance of Enwave Corporation vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Enwave Corporation | -6.310% | -8.962% | -18.220% | 26.974% | -18.220% | -26.195% | -76.803% |
| Aurinia Pharmaceuticals Inc. | -0.080% | -0.203% | -8.946% | 59.451% | -8.946% | 48.883% | -10.930% |
| Spectral Medical Inc | -1.270% | 0.000% | -1.887% | 132.143% | -1.887% | 257.798% | 161.745% |
| Xenon Pharmaceuticals Inc. | -0.570% | -1.695% | -8.421% | -10.309% | -8.421% | -1.136% | - |
News
EnWave Reports 2025 Fourth Quarter and Annual 2025 Consolidated Financial Results
Vancouver, B.C., December 15th, 2025 / EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") today reported the Company’s consolidated interim financial results for the fourth
EnWave Signs Royalty-Bearing Commercial License with Shinyway International Limited of New Zealand
Vancouver, B.C., November 12th, 2025 – EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") announced today that it has signed a royalty-bearing, commercial license agreement
EnWave Signs Royalty-Bearing Commercial License with U.S. Snacking Company, Sells 10kW Radiant Energy Vacuum Machinery
Vancouver, B.C., November 10th, 2025 / EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") announced today that it has signed a royalty-bearing, commercial license agreement

